Irodalom:
1. Hedin C, Whelan K, Lindsay JO: Evidence for the use of probiotics and prebiotics in inflammatory
bowel disease: a review of clinical trials. Proc Nutr Soc. 2007 Aug;66(3):307-15.
2. Geier MS, Butler RN, Howarth GS: Inflammatory bowel disease: current insights into pathogenesis and
new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol. 2007 Apr 1;115(1):1-11.
3. Mallon P, McKay D, Kirk S, Gardiner K: Probiotics for induction of remission in ulcerative colitis.
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005573.
498 Gastro Update 2008
4. Leenen CH, Dieleman LA: Inulin and oligofructose in chronic inflammatory bowel disease. J Nutr.
2007 Nov;137(11 Suppl):2572S-2575S.
5. Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus Jet al: Comparative study of the
preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus
acidophilus, in the TNBS model of rat colitis. J Appl Microbiol. 2007 Oct;103(4):836-44.
6. Fitzpatrick LR, Hertzog KL, Quatse AL, Koltun WA, Small JS, Vrana K: Effects of the probiotic formulation
VSL#3 on colitis in weanling rats. J Pediatr Gastroenterol Nutr. 2007 May;44(5):561-70.
7. Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS: Anti-in
flammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the
interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol. 2007
Oct;293(4):G729-38.
8. Cuomo R, Savarese MF, Gargano R: Almost all irritable bowel syndromes are post-infectious and
respond to probiotics: consensus issues. Dig Dis. 2007;25(3):241-4.
9. Quigley EM. Bacteria: a new player in gastrointestinal motility disorders–infections, bacterial overgrowth,
and probiotics. Gastroenterol Clin North Am. 2007 Sep;36(3):735-48.
10. Quigley EM: Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for
management. J Dig Dis. 2007 Feb;8(1):2-7.
11. Guslandi M: Probiotic agents in the treatment of irritable bowel syndrome. J Int Med Res. 2007 SepOct;35(5):583-9.
12. Borowiec AM, Fedorak RN: The role of probiotics in management of irritable bowel syndrome. Curr
Gastroenterol Rep. 2007 Oct;9(5):393-400.
13. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH et al: Effect of a fermented
milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms
in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled
trial. Aliment Pharmacol Ther. 2007 Aug 1;26(3):475-86.
14. Kajander K, Krogius-Kurikka L, Rinttilû T, Karjalainen H, Palva A, Korpela R: Effects of multispecies
probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol
Ther. 2007 Aug 1;26(3):463-73.
15. Dughera L, Elia C, Navino M, Cisarò F: ARMONIA Study Group. Effects of symbiotic preparations
on constipated irritable bowel syndrome symptoms. Acta Biomed. 2007 Aug;78(2):111-6.
16. Stein GY, Nanim R, Karniel E, Moskowitz I, Zeidman A: Probiotics as prophylactic agents against
antibiotic-associated diarrhea in hospitalized patients. Harefuah. 2007 Jul;146(7):520-2, 575.
17. Beausoleil M, Fortier N, Guénette S, L’ecuyer A, Savoie M, Franco M et al: Effect of a fermented milk
combining lactobacillus acidophilus Cl1285 and lactobacillus casei in the prevention of antibiotic-associated
diarrhea: A randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007 Nov;
21(11):732-6.
18. Wullt M, Johansson Hagslûtt ML, Odenholt I, Berggren A: Lactobacillus plantarum 299v enhances the
concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated
diarrhea. Dig Dis Sci. 2007 Sep;52(9):2082-6.
19. Hickson M, D’Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ: Use of probiotic Lactobacillus
preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo con
trolled trial. BMJ. 2007 Jul 14;335(7610):80.
20. Demeter P: A probiotikumok alkalmazásának lehetõségei emésztõszervi betegségekben. LAM
2006;16(1):41-47.
Gyógyszerek, therápia 499
21. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP: Lactobacillus acidophilus inhibits growth of
Campylobacter pylori in vitro. J Clin Microbiol 1989;27:2328-30.
22. Lorca GL, Wadstrom T, Valdez GF: Ljungh A. Lactobacillus acidophilus autolysins inhibit Helicobacter
pylori in vitro. Curr Microbiol 2001;42:39-44.
23. Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F et al: A lyophilized and inactivated
culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol
Ther 2000;14:1625-9.
24. Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL: Helicobacter pylori and probiotics. J Nutr.
2007 Mar;137(3 Suppl 2):812S-8S.
25. Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D, Gigante G et al: Role of probiotics in
patients with Helicobacter pylori infection. Helicobacter. 2007 Nov;12 Suppl 2:59-63.
26. Imase K, Tanaka A, Tokunaga K, Sugano H, Ishida H, Takahashi S: Lactobacillus reuteri tablets suppress
Helicobacter pylori infection–a double-blind randomised placebo-controlled cross-over clinical study.
Kansenshogaku Zasshi. 2007 Jul;81(4):387-93.
27. Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S, Korpela R: Effects of anti-Helicobacter
pylori treatment and probiotic supplementation on intestinal microbiota. Int J Antimicrob Agents. 2007
Jan;29(1):66-72.
28. Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S: Efficacy and safety of Saccharomyces boulardii
in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled doubleblind
study. Helicobacter. 2007 Aug;12(4):309-16.
29. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics
on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol
Ther. 2007 Jan 15;25(2):155-68.
30. Solga SF: Probiotics can treat hepatic encephalopathy. Medical Hypotheses 2003;61:307-13.
31. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA: Bifidobacterium
longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized,
double-blind, placebo-controlled study. Dig Dis Sci. 2007 Nov;52(11):3259-65.
32. Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM: VSL#3 Probiotic Treatment
Reduces Chemotherapy-Induced Diarrhea and Weight Loss. Cancer Biol Ther. 2007 Jun 23;6(9).
33. Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P et al: Lactobacillus supplementation
for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 2007 Oct
22;97(8):1028-34.
